and Markets has announced the addition of the "Drug Delivery Using
Nanotechnologies: Technologies, Markets and Competitive Environment" report
to their offering.
Drug delivery commands a sizeable proportion of the overall pharmaceutical
market, approximately 15% or some US 109 billion in 2008. It is also expected
to grow at a faster rate than the overall pharmaceutical market over the next
4 years. The reason Extending patent life for existing drugs and offering new
alternatives for delivery, in particular the peroral route.
In all of this nanotechnology is a major enabler. Previously insoluble drugs
can be re-packaged or formulated both increasing efficacy and decreasing the
need for solvents. Greater stability can be assured by novel nanostructured
materials and processes utilising nanotechnology. Such developments are not
going unnoticed, with strategic collaborations, mergers and acquisitions becoming
This report, written by Tiju Joseph and Richard Moore of the Institute of Nanotechnology,
provides a comprehensive overview of these new technologies and a market analysis
of opportunities to 2012. It concludes with a description of over 40 emerging
companies in this exciting and fast-developing field.
- Abraxis Biosciences Inc. - Access Pharmaceuticals Inc. - Allergan Inc. -
ALZA Corporation - Aphios Corporation - Artificial Cell Technologies - Avidimer
Therapeutics - Azaya Therapeutics - Baxter Healthcare - BioAlliance Pharma -
Biodelivery Sciences International - Biophan - Calando Pharmaceuticals - Capsulution
Nanosciences AG - Dabur Research Foundation - Elan Corporation - Endovasc -
Enzon Pharmaceuticals Inc - Exilica Ltd - Flamel Technologies - Gilead Sciences,
Inc - ICeutica - Insert Therapeutics - ImuThes Ltd - Intezyne Technologies -
Keystone Nano - Labopharm - Magforce Nanotechnologies - Nanocarrier - Nanocopoeia
- NanoBioMagnetics - Nanobiotix - Nanomerics - Nanotherapeutics - NanoViricides
Inc - Neopharm - Novosom - Psividia - SamYang - Spherics - Starpharma - Skyepharma
- Tekmira Pharmaceuticals Corporation - XstalBio
For more information visit http://www.researchandmarkets.com/research/683fce/drug_delivery_usin.